Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation radiopharmaceuticals for the treatment of cancer, today announced compelling results from Part 2 of the ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted ...
In the new guidance, the agency has concluded that AI-Rad Companion Prostate MR, DeepHealth Prostate, ProstatID, Prostate ...
STAMPEDE study analysis providing new predictive evidence in clinically very high-risk, nonmetastatic disease to be presented at ESMOSOUTH SAN FRANCISCO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- ...
Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 3.5 million men in the United States who have been diagnosed with prostate ...
A DNA test for prostate cancer patients could spare men unnecessary chemotherapy according to a study. A trial of 6,000 patients found the genetic test, known as Decipher, could indicate who would ...
Daily Mail on MSN
Hope for thousands as prostate cancer test identifies who will benefit from aggressive treatment
Thousands of men with high-risk prostate cancer could soon live longer, thanks to a test that helps doctors identify which ...
A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.
Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An ...
Five artificial intelligence tools for more accurately detecting prostate cancer in MRI scans have been approved for use on ...
Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive ...
Your body absorbs more of this food’s key antioxidant when it’s heated.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results